NeuroRx, Inc.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Public, Subsidiary
- Established
- 2015-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.neurorxpharma.com
NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- NeuroRx, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT06128213
NRX-101 Expanded Access
- First Posted Date
- 2023-03-22
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- NeuroRx, Inc.
- Registration Number
- NCT05779267
Phase 2b/3 Trial of VSV-ฮG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- NeuroRx, Inc.
- Registration Number
- NCT04990466
NRX101 Glx Biomarker Validation Study
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- NeuroRx, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT03402152
- Locations
- ๐บ๐ธ
New York State Psychiatric Institute, New York, New York, United States
NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2018-01-11
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- NeuroRx, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT03396601
- Locations
- ๐บ๐ธ
JP Smith Hospital, Fort Worth, Texas, United States
๐บ๐ธResearch Centers of America, Hollywood, Florida, United States
NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2018-01-10
- Last Posted Date
- 2024-01-19
- Lead Sponsor
- NeuroRx, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT03396068
- Locations
- ๐บ๐ธ
JP Smith Hospital, Fort Worth, Texas, United States
๐บ๐ธResearch Site, Birmingham, Birmingham, Alabama, United States
๐บ๐ธResearch Centers of America, Hollywood, Florida, United States
NRX-101 for Bipolar Depression With Subacute Suicidal Ideation
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-01-10
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- NeuroRx, Inc.
- Target Recruit Count
- 74
- Registration Number
- NCT03395392
- Locations
- ๐บ๐ธ
iResearch Atlanta, LLC, Decatur, Georgia, United States
๐บ๐ธiResearch Savannah, Savannah, Georgia, United States
๐บ๐ธPeace Health Medical Group, Eugene, Oregon, United States
Sequential Therapy for the Treatment of Severe Bipolar Depression.
- First Posted Date
- 2016-11-28
- Last Posted Date
- 2021-05-25
- Lead Sponsor
- NeuroRx, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT02974010
- Locations
- ๐บ๐ธ
Research Site, Birmingham, Birmingham, Alabama, United States
๐บ๐ธResearch Site, Charlotte, Charlotte, North Carolina, United States
๐บ๐ธResearch Site, Houston, Houston, Texas, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath